Monitored Therapeutics, Inc. — Form D
Monitored Therapeutics, Inc. of DUBLIN, OH, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-08. The offering totals $2.0M, of which $105K was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-11-08
- Form: D
- Accession: 0001721865-17-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $105K
- Remaining: $1.9M
- Minimum investment: $5K
- Investors: 2
- Date of first sale: 2017-10-20
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-298350
Issuer
- Name: Monitored Therapeutics, Inc.
- CIK: 0001721865
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5995 Shier Rings Road, DUBLIN, OH, 43016
- Phone: 6147613555
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| William Stock Ross | Director | Las Vegas, NV |
| Alex Charles Stenzler | Director | Lond Beach, CA |
| Michael Stock Taylor | Director | Dublin, OH |
| William Charles Zimlich | Director | Dublin, OH |
| William Charles Zimlich | Executive Officer | Dublin, OH |
| MARK SHARY | Director | Indianapolis, IN |
| Michael Taylor | Director | Westlake Village, CA |
| Michael Taylor | Executive Officer | Westlake Village, CA |
| William Ross | Director | Grand Bay, AL |
| Kamnikar Jim | Executive Officer | Dublin, OH |
| James Kamnikar | Executive Officer | Powell, OH |
| Steve Han | Director | Huntington Beach, CA |
| Alex Stenzler | Director | Long Beach, CA |
| Barry Sugarman | Director | Pacific Palisades, CA |
Other filings by this issuer (2)
More